279 related articles for article (PubMed ID: 27039301)
1. Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis.
Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmström V
Arthritis Res Ther; 2016 Apr; 18():80. PubMed ID: 27039301
[TBL] [Abstract][Full Text] [Related]
2. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
[TBL] [Abstract][Full Text] [Related]
3. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
4. Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.
Loell I; Raouf J; Chen YW; Shi R; Nennesmo I; Alexanderson H; Dastmalchi M; Nagaraju K; Korotkova M; Lundberg IE
Arthritis Res Ther; 2016 Jun; 18(1):136. PubMed ID: 27287443
[TBL] [Abstract][Full Text] [Related]
5. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
[TBL] [Abstract][Full Text] [Related]
6. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis.
Iannone F; Cauli A; Yanni G; Kingsley GH; Isenberg DA; Corrigall V; Panayi GS
Br J Rheumatol; 1996 Sep; 35(9):839-45. PubMed ID: 8810666
[TBL] [Abstract][Full Text] [Related]
7. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.
Dorph C; Englund P; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2006 Dec; 65(12):1565-71. PubMed ID: 16831829
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis.
Korotkova M; Helmers SB; Loell I; Alexanderson H; Grundtman C; Dorph C; Lundberg IE; Jakobsson PJ
Ann Rheum Dis; 2008 Nov; 67(11):1596-602. PubMed ID: 18094001
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
10. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
11. Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.
Ye J; Liu Q; Fu Q; Li B; Huang J; Zeng G
J Coll Physicians Surg Pak; 2023 Apr; 33(4):421-426. PubMed ID: 37190715
[TBL] [Abstract][Full Text] [Related]
12. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
13. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.
Page G; Chevrel G; Miossec P
Arthritis Rheum; 2004 Jan; 50(1):199-208. PubMed ID: 14730617
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
[TBL] [Abstract][Full Text] [Related]
15. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
[TBL] [Abstract][Full Text] [Related]
16. Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients.
Loell I; Helmers SB; Dastmalchi M; Alexanderson H; Munters LA; Nennesmo I; Lindroos E; Borg K; Lundberg IE; Esbjörnsson M
Clin Physiol Funct Imaging; 2011 Jan; 31(1):18-25. PubMed ID: 21029327
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
19. Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.
Espinosa-Ortega F; Gómez-Martin D; Santana-De Anda K; Romo-Tena J; Villaseñor-Ovies P; Alcocer-Varela J
Clin Exp Immunol; 2015 Mar; 179(3):520-8. PubMed ID: 25348796
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
